, so that the necessary doses are guaranteed to the entire population.
Asked about the doses that were used by officials outside clinical trials, the Peruvian leader indicated that his administration is characterized for not speculating or providing any hypotheses.
Moreover, Mr. Sagasti assured that none dose or figure will remain unjustified, as it will be known where they ended up.
"What we can do is guarantee the integrity of the clinical trials that have been conducted in Peru. What has happened is an aberration that should be treated as such and that should not affect (…) the well-earned prestige of Peru in the hosting of clinical trials," he concluded.